Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KBIO | SLGL | MGX | ||
| Company | Kalobios Pharmaceuticals Inc | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 1.6500 | 71.79 | 1.1300 | ||
| High | 2.2000 | 72.48 | 1.2194 | ||
| Low | 1.6200 | 70.10 | 1.1300 | ||
| Latest | 2.1900 | 70.36 | 1.1800 | ||
| Change | +0.4630 | -2.51 | +0.0400 | ||
| % Change | +26.81% | -3.44% | +3.51% | ||
| Volume | 29,900 | 26,000 | 100,000 | ||
| 20-Day Average Volume | 12,700 | 44,195 | 174,205 | ||
| Previous Close | 1.7270 | 72.87 | 1.1400 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.7043 | 73.56 | 1.2845 | ||
| 20-Day Raw Stochastic | 98.57% | 39.13% | 17.24% | ||
| 20-Day Relative Strength | 60.40 | 47.14 | 38.03 | ||
| Weighted Alpha | -53.96 | +310.82 | -35.59 | ||
| Today's Opinion | N/A | 24% Buy | 100% Sell | ||
| Previous Opinion | N/A | 24% Buy | 100% Sell | ||
| Last Month's Opinion | N/A | 24% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +36.88% since 07/28/17 | -4.27% since 06/10/26 | -4.07% since 06/10/26 | ||
| Low | 1.5700 on 08/02/17 | 70.10 on 06/17/26 | 1.1300 on 06/17/26 | ||
| High | 2.2000 on 08/04/17 | 76.99 on 06/11/26 | 1.2800 on 06/12/26 | ||
| 1-Month | |||||
| %Chg | +12.31% since 07/03/17 | -3.25% since 05/15/26 | -9.92% since 05/15/26 | ||
| Low | 1.5000 on 07/11/17 | 62.50 on 05/19/26 | 1.1300 on 06/17/26 | ||
| High | 2.2000 on 08/04/17 | 81.53 on 05/29/26 | 1.4200 on 05/27/26 | ||
| 3-Month | |||||
| %Chg | -5.60% since 05/04/17 | -11.77% since 03/17/26 | -19.18% since 03/17/26 | ||
| Low | 1.5000 on 07/11/17 | 61.92 on 03/23/26 | 1.1300 on 06/17/26 | ||
| High | 2.9500 on 05/17/17 | 93.53 on 03/24/26 | 1.5500 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | -28.20% since 02/03/17 | +70.98% since 12/17/25 | -28.05% since 12/17/25 | ||
| Low | 1.5000 on 07/11/17 | 38.91 on 12/19/25 | 1.1300 on 06/17/26 | ||
| High | 3.2500 on 02/17/17 | 97.97 on 03/03/26 | 1.8700 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 32,806 | 204,757 | 42,918 | ||
| Shares Outstanding, K | 14,980 | 2,810 | 37,647 | ||
| Annual Sales | 0 | 19,390,000 | 25,210,000 | ||
| Annual Net Income | -27,010,000 | -6,130,000 | -87,870,000 | ||
| Last Quarter Sales | N/A | 110,000 | 1,250,000 | ||
| Last Quarter Net Income | N/A | -3,730,000 | -23,060,000 | ||
| 60-Month Beta | 2.99 | 1.13 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.31 on 05/28/26 | -0.61 on 05/11/26 | ||
| Earnings Date | 09/22/17 | 08/21/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||